Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Replacement in Congenital Hypogonadotropic Hypogonadism
NCT02111473Phase 4Completed
- Sponsor
- Gulhane School of Medicine
- Start
- May 2009
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of testosterone in Congenital Hypogonadotropic Hypogonadism (CHH), sponsored by Gulhane School of Medicine. Started May 2009; status: completed.
02
Drugs
testosterone
03
Conditions
Congenital Hypogonadotropic Hypogonadism (CHH)
Beyond the preview
Go deeper on NCT02111473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02111473.